Girish Venkatachaliah - 14 Apr 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Technology Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2023
Net transactions value
-$38,620
Form type
4
Filing time
18 Apr 2023, 16:51:47 UTC
Previous filing
29 Sep 2022
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +21,961 +139% $0.000000 37,756 14 Apr 2023 Direct F1, F2, F3
transaction AGL Common Stock Tax liability $38,620 -1,357 -3.6% $28.46 36,399 14 Apr 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +37,971 $0.000000 37,971 14 Apr 2023 Common Stock 37,971 $28.46 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.
F2 Includes restricted stock units.
F3 The total was decreased by 476 shares as reported in the Form 4 Amendment filed on September 29, 2022.
F4 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F5 Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment.

Remarks:

Exhibit List: Ex.24 - Power of Attorney